Reuters logo
2 years ago
BRIEF-Novartis says Sandoz buys Pfizer's biosimilar infliximab in EEA
February 12, 2016 / 6:06 AM / 2 years ago

BRIEF-Novartis says Sandoz buys Pfizer's biosimilar infliximab in EEA

Feb 12 (Reuters) - Novartis Ag

* Says sandoz strengthens its biosimilars portfolio with acquisition of pfizer's biosimilar infliximab in eea

* says sandoz plans to complete phase iii development program and file for registration in eu Source text for Eikon: Further company coverage: (Reporting by John Miller)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below